全文获取类型
收费全文 | 11357篇 |
免费 | 654篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 137篇 |
妇产科学 | 180篇 |
基础医学 | 761篇 |
口腔科学 | 464篇 |
临床医学 | 955篇 |
内科学 | 1089篇 |
皮肤病学 | 111篇 |
神经病学 | 348篇 |
特种医学 | 526篇 |
外科学 | 2824篇 |
综合类 | 1519篇 |
一般理论 | 1篇 |
预防医学 | 849篇 |
眼科学 | 111篇 |
药学 | 1472篇 |
12篇 | |
中国医学 | 369篇 |
肿瘤学 | 264篇 |
出版年
2023年 | 254篇 |
2022年 | 330篇 |
2021年 | 592篇 |
2020年 | 557篇 |
2019年 | 467篇 |
2018年 | 460篇 |
2017年 | 437篇 |
2016年 | 422篇 |
2015年 | 413篇 |
2014年 | 903篇 |
2013年 | 970篇 |
2012年 | 672篇 |
2011年 | 744篇 |
2010年 | 544篇 |
2009年 | 501篇 |
2008年 | 481篇 |
2007年 | 453篇 |
2006年 | 403篇 |
2005年 | 337篇 |
2004年 | 293篇 |
2003年 | 234篇 |
2002年 | 190篇 |
2001年 | 172篇 |
2000年 | 125篇 |
1999年 | 148篇 |
1998年 | 119篇 |
1997年 | 84篇 |
1996年 | 81篇 |
1995年 | 85篇 |
1994年 | 62篇 |
1993年 | 44篇 |
1992年 | 30篇 |
1991年 | 36篇 |
1990年 | 36篇 |
1989年 | 33篇 |
1988年 | 36篇 |
1987年 | 34篇 |
1986年 | 19篇 |
1985年 | 34篇 |
1984年 | 41篇 |
1983年 | 26篇 |
1982年 | 36篇 |
1981年 | 30篇 |
1980年 | 20篇 |
1979年 | 30篇 |
1978年 | 18篇 |
1977年 | 20篇 |
1976年 | 18篇 |
1975年 | 15篇 |
1974年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
【目的】 以J-Stage平台的概况和日本科技期刊的语种分类为基础,深入分析J-Stage的实施细节及其在推动日本科技期刊发展中的关键作用与角色,对我国期刊发展形成启示。【方法】 采用前瞻研究法,从平台架构、组织和功能方面分析J-Stage的发展现状,并结合日本科技期刊的语种分类进行分析。【结果】 J-Stage的特色在于整合全国学术期刊资源、采取公益性运行机制、重视用户体验、不断更新服务、对接国际标准等,对我国期刊平台建设具有一定的借鉴意义。【结论】 J-Stage的建设有利于日本多语种科技期刊的共同发展和国际影响力提升。国家级科技期刊平台不仅是期刊发展的基础设施,还要兼具前瞻性导向作用和精益管理能力。 相似文献
5.
6.
《Seminars in Arthroplasty》2022,32(4):681-687
BackgroundThe objective of this study was to compare complication rates between patients undergoing reverse shoulder arthroplasty (RSA) after a prior open reduction and internal fixation (ORIF) for proximal humerus fracture (PHF) to those undergoing RSA as a primary treatment for PHFs, glenohumeral osteoarthritis, or rotator cuff tear arthropathy (CTA).MethodsPatients who underwent RSA between 2015 and 2020 were identified in the Mariner database. Patients were separated into 3 mutually exclusive groups: (1) RSA for osteoarthritis, rotator cuff tear, or CTA (Control-RSA); (2) RSA as a primary treatment for PHF (PHF-RSA); and (3) RSA for patients with prior ORIF of PHFs (ORIF-RSA). Ninety-day medical and 2-year postoperative surgical complications were identified. In addition, patients in the PHF-RSA group were subdivided into those undergoing RSA for PHF within 3 months of the fracture (acute) vs. those treated greater than 3 months from diagnosis (delayed). Multivariate regression was performed to control for differences in comorbidities and demographics.ResultsA total of 30,824 patients underwent primary RSA for arthritis or CTA, 5389 patients underwent RSA as a primary treatment for a PHF, and 361 patients underwent RSA after ORIF of a PHF. ORIF before RSA was associated with an increased risk of overall revision (odds ratio [OR] 2.45, P = .002), infection (OR 2.40, P < .001), instability (OR 2.43, P < .001), fracture (OR 3.24, P = .001), minor medical complications (OR 1.59, P = .008), and readmission (OR 2.55, P = .001) compared with the Control-RSA cohort. RSA as a primary treatment for PHF was associated with an increased risk of 2-year revision (OR 1.60, P < .001), infection (OR 1.51, P < .001), instability (OR 2.84, P < .001), and fracture (OR 2.54, P < .001) in addition to major medical complications (OR 2.02, P < .001), minor medical complications (OR 1.92, P < .001), 90-day emergency department visits (OR 1.26, P < .001) and 90-day readmission (OR 2.03, P < .001) compared with the Control-RSA cohort. The ORIF-RSA group had an increased risk of periprosthetic infection (OR 1.94, P = .002) when compared with the PHF-RSA cohort. There were no differences in medical or surgical complications in the RSA-PHF cohort between patients treated in an acute or delayed fashion.ConclusionRSA following ORIF of a PHF is associated with increased complications compared with patients undergoing RSA for nonfracture indications. Prior ORIF of a PHF is also an independent risk factor for postoperative infection after RSA compared with patients who undergo RSA as a primary operation for fracture. The timing of RSA as a primary operation for PHF does not appear to impact the rates of postoperative medical and surgical complications. 相似文献
7.
8.
9.
《Journal of Clinical Orthopaedics and Trauma》2021,12(6):976-982
ObjectiveMultiple treatment options for acetabular fractures in geriatric patients exist. However, no large-scale studies have reported the outcomes of acute total hip arthroplasty (THA) in this patient population. We systematically evaluated all available evidence to characterize clinical outcomes, complications, and revisions of acute THA for acetabular fractures in geriatric patients.MethodsMeta-analysis of 21 studies of 430 acetabular fractures with mean follow-up of 44 months (range, 17−97 months). Two independent researchers searched and evaluated the databases of Ovid, Embase, and United States National Library of Medicine using a Boolean search string up to December 2019. Population demographics and complications, including presence of heterotopic ossification (HO), dislocation, infection, revision rate, neurological deficits, and venous thromboembolic event (VTE), were recorded and analyzed.ResultsWeighted mean Harris Hip Score was 83.3 points, and 20% of the patients had reported complications. The most common complication was HO, with a rate of 19.5%. Brooker grade III and IV HO rates were lower at 6.8%. Hip dislocation occurred at a rate of 6.1%, 4.1% of patients developed VTE, deep infection occurred in 3.8%, and neurological complications occurred in 1.9%. Although the revision rate was described in most studies, we were unable to perform a survival analysis because the time to each revision was described in only a few studies. The revision rate was 4.3%.ConclusionsAcute THA is a viable option for treatment of acetabular fracture and can result in acceptable clinical outcomes and survivorship rates in older patients but with an associated complication rate of approximately 20%. Considering the limited treatment options, THA might be a viable alternative for appropriately selected patients. 相似文献
10.
《Journal of the American College of Radiology》2021,18(10):1394-1404
ObjectiveKidney stones are common, tend to recur, and afflict a young population. Despite evidence and recommendations, adoption of reduced-radiation dose CT (RDCT) for kidney stone CT (KSCT) is slow. We sought to design and test an intervention to improve adoption of RDCT protocols for KSCT using a randomized facility-based intervention.MethodsFacilities contributing at least 40 KSCTs to the American College of Radiology dose index registry (DIR) during calendar year 2015 were randomized to intervention or control groups. The Dose Optimization for Stone Evaluation intervention included customized CME modules, personalized consultation, and protocol recommendations for RDCT. Dose length product (DLP) of all KSCTs was recorded at baseline (2015) and compared with 2017, 2018, and 2019. Change in mean DLP was compared between facilities that participated (intervened-on), facilities randomized to intervention that did not participate (intervened-off), and control facilities. Difference-in-difference between intervened-on and control facilities is reported before and after intervention.ResultsOf 314 eligible facilities, 155 were randomized to intervention and 159 to control. There were 25 intervened-on facilities, 71 intervened-off facilities, and 96 control facilities. From 2015 to 2017, there was a drop of 110 mGy ∙ cm (a 16% reduction) in the mean DLP in the intervened-on group, which was significantly lower compared with the control group (P < .05). The proportion of RDCTs increased for each year in the intervened-on group relative to the other groups for all 3 years (P < .01).DiscussionThe Dose Optimization for Stone Evaluation intervention resulted in a significant (P < .05) and persistent reduction in mean radiation doses for engaged facilities performing KSCTs. 相似文献